Reciprocal Activation Between Nicotinamide N-Methyltransferase and TGF-β Signaling Promotes Hepatic Stellate Cell Activation and Liver Fibrosis
Kim NY, Lee JH, Cho SS, Kim JH, Park TH, Kang S, Yang JH, Kim TH, Park EY, Jung YS, Ki SH
- International Journal of Biological Sciences (2026) Accepted (IF: 11.7, JCR 7.9%)
Park C, Oh H, Jang CY, Kim TH
- Antioxidants (2026) 15(11): 1410 (IF: 8.2, JCR 6.9%)
Pham HT, Kim S, Hong J, Gwon D, Choi S, Kim W, Ngo MT, Jang J, Doan TP, Oh WK, Lim YW, Kim TH, Kim DH, Jang CY, Kang KB
- Bioorganic Chemistry (2026) 180:110130 (IF: 5.1, JCR 6.9%)
Exploring NNMT: from metabolic pathways to therapeutic targets
Park J, Shin EJ, Kim TH, Yang JH, Ki SH, Kang KW, Kim KM
- Archives of Pharmacal Research (2024) 47(12):893-913 (IF: 8.2, JCR 6.9%) (Review)
Kim DH, Kim J, Park J, Kim TH, Han YH
- Life Sciences (2024) 356:123042 (IF: 6.4, JCR 11.8%)
Epsti1 Regulates the Inflammatory Stage of Early Muscle Regeneration through STAT1-VCP Interaction.
Kim JW, Bae JH, Go GY, Lee JR, Jeong Y, Kim JY, Kim TH, Kim YK, Han JW, Oh JE, Hahn MJ, Kang JS, Bae GU
- International Journal of Biological Sciences (2024) 20(9): 3530-3543 (IF: 11.7, JCR 7.9%)
Fortibui MM$, Park C$, Kim NY, Kim TH*, Lee MH*
- Analytical Chemistry (2024) 96: 9408-9415 (IF: 7.3, JCR 5.5%) ($equally contributed; *co-correspondence)
Kim TH
- Journal of Ginseng Research (2024) 48(3): 276-285 (IF: 7.5, JCR 6.3%) (Review)
Park S, Hwang S, Sun J, Jeon KH, Sheen N, Shin S, Kim TH, Lee YS, Seo W, Ryu JS, Kwon Y.
- International Journal of Biological Sciences (2024) 20(5): 1855-1870 (IF: 11.7, JCR 7.9%)
Ginsenoside Rg5 promotes muscle regeneration via p38MAPK and Akt/mTOR signaling.
Kim R, Kim JW, Choi H, Oh JE, Kim TH, Go GY, Lee SJ, Bae GU.
- Journal of Ginseng Research (2023) 47:726-734 (IF: 7.5, JCR 6.3%)
Targeting liver X receptors for the treatment of non-alcoholic fatty liver disease.
Kim H, Park C, Kim TH.
- Cells (2023) 12(9): 1292 (IF: 6.0, JCR 28.5%) (Review)
Ha Y*, Jeong I*, Kim TH.
- Biomedicines (2022) 10:2530. (IF: 4.5, JCR 30.9%) (Review) (*equally contributed)
Tak J, Kim YS, Kim TH, Park GC, Hwang S, Kim SG.
- Theranostics (2022) 12(4):1570-1588. (IF: 14.9, JCR 3.1%)
NRF2-mediated SIRT3 induction protects hepatocytes from ER stress-induced liver injury.
Kim A, Koo JH, Lee JM, Joo MS, Kim TH, Kim H, Jun DW, Kim SG.
- FASEB J (2022) 36(3):e22170. (IF: 4.3, JCR 17.9%)
Hepatokines and Non-Alcoholic Fatty Liver Disease: Linking Liver Pathophysiology to Metabolism.
Kim TH, Hong DG, Yang YM.
- Biomedicines (2021) 9:1903. (IF: 4.5, JCR 30.9%) (Review)
Kim TH, Koo JH, Heo MJ, Han CY, Kim YI, Park SY, Cho IJ, Lee CH, Choi CS, Lee JW, Kim W, Cho JY, Kim SG.
- Science Translational Medicine (2019) 11(513):eann4735. (IF: 15.6, JCR 2.6%)
Wu HM, Kim TH, Kim A, Koo JH, Joo MS, Kim SG.
- Hepatology Communications (2019) 3(10):1373-1387. (IF: 6.0, JCR 17.0%)
Role of CXCR6 in Antitumor Immune Surveillance.
Kim TH, Kim SG.
- Gastroenterology (2019) 156(6):1565-1568. (IF: 29.7, JCR 2.6%) (Editorial)
Joo MS, Koo JH, Kim TH, Kim YS, Kim SG.
- EbioMedicine (2019) 40:488-503. (IF: 11.2, JCR 9.9%)
Heo MJ, Kim TH, You JS, Blaya D, Sancho-Bru P, Kim SG.
- Gut (2019) 68:704-720. (IF: 24.6, JCR 3.3%)
Kim TH*, Yang YM*, Han CY, Koo JH, Oh H, Kim SS, You BH, Choi YH, Park TS, Lee CH, Kurose H, Noureddin M, Seki E, Wan YY, Choi CS, Kim SG.
- Journal of Clinical Investigation (2018) 128(12):5587-5602. (IF: 14.3, JCR 5.2%) (*equal contribution)
Han CY, Rho HS, Kim A, Kim TH, Jang K, Jun DW, Kim JW, Kim B, Kim SG.
- Cell Reports (2018) 24(11):2985-2999. (IF: 7.7, JCR 21.3%)
Gα13 ablation reprograms myofibers to oxidative phenotype and enhances whole-body metabolism.
Koo JH, Kim TH, Park SY, Joo MS, Han CY, Choi CS, Kim SG.
- Journal of Clinical Investigation (2017) 127(10):3845-3860. (IF: 14.3, JCR 5.2%)
Farnesoid X receptor as a regulator of fuel consumption and mitochondrial function.
Han CY*, Kim TH*, Koo JH, Kim SG.
- Archives of Pharmacal Research (2016) 39(8):1062-1074. (IF: 8.2, JCR 6.9%) (*equal contribution)
Yang YM, Lee CG, Koo JH, Kim TH, Lee JM, An J, Kim KM, Kim SG.
- Oncotarget (2015) 6(22):19055-19069.
Shin SY*, Kim TH*, Wu H, Choi YH, Kim SG.
- European Journal of Pharmacology (2014) 727:115-124. (IF: 5.7, JCR 14.6%) (*equal contribution)
Kim TH, Eom JS, Lee CG, Yang YM, Lee YS, Kim SG.
- British Journal of Pharmacology (2013) 168(7):1647-1161. (IF: 7.5, JCR 7.6%)
Yang YM, Seo SY, Kim TH, Kim SG.
- Hepatology (2012) 56(6):2209-2220. (IF: 18.0, JCR 4.6%)
Kim TH, Kim SG.
- Safety and Health at Work (2011) 2(2):97-104. (IF: 3.2, JCR 27.1%) (Review)
Kim YM*, Kim TH*, Kim YW, Yang YM, Ryu da H, Hwang SJ, Lee JR, Kim SC, Kim SG.
- Free Radical Biology and Medicine (2010) 49(11):1722-1734. (IF: 8.0, JCR 8.6%) (*equal contribution)
Kay HY, Won Yang J, Kim TH, Lee da Y, Kang B, Ryu JH, Jeon R, Kim SG.
- Journal of Nutrition (2010) 140:1211-1219. (IF: 4.2, JCR 28.9%)
Kim TH, Kim YW, Shin SM, Kim CW, Yu IJ, Kim SG.
- Chemico-Biological Interactions (2010) 184(3):492-501. (IF: 5.2, JCR 15.1%)
Kim YW, Kim YM, Yang YM, Kim TH, Hwang SJ, Lee JR, Kim SC, Kim SG.
- Free Radical Biology and Medicine (2010) 48(4):567-578. (IF: 8.0, JCR 8.6%)